



2011, Vol. 18, No. 5, pp. 577–580
10.5603/CJ.2011.0019
Copyright © 2011 Via Medica
ISSN 1897–5593
Address for correspondence: Konstantinos Lampropoulos, MD, PhD, FESC, Department of Cardiology, Polyclinic General
Hospital of Athens, Greece, 31, L. Porfyra str., 16673, Athens, Greece, tel: +302 108 950 863, fax: +302 108 950 863,
e-mail: konlampropoulos@yahoo.gr
Received: 28.03.2011 Accepted: 20.06.2011
Continuity equation is the echocardiographic method
of choice to assess degenerative mitral stenosis
Maria Bonou, Apostolos-Ilias Vouliotis, Konstantinos Lampropoulos,
John Lakoumentas, Maria Andriopoulou, Achileas Kotsakis, John Barbetseas
Department of Cardiology, Polyclinic General Hospital of Athens, Greece
Abstract
We present a rare case of a patient with severe, symptomatic degenerative calcific mitral
stenosis (MS). Calcification of mitral valve annulus (MVA) is a frequent finding in elderly
patients. It can be isolated or associated more often with mitral valve insufficiency than MS. In
rare cases, it results in severe MS. An accurate measurement of MVA in degenerative calcific
MS is problematic because the limiting orifice is near the annulus and not at the leaflet tips as
in rheumatic MS. Continuity equation is the best echocardiographic method to assess the MVA
in degenerative MS, correlating well with invasive methods. Real-time three-dimensional
echocardiography is a promising tool and provides an accurate measurement of MVA in
calcific MS, with a very good correlation compared to continuity equation. On the other hand,
the use of pressure half-time is often inaccurate and should be avoided, while two-dimensional
planimetry is difficult and not reliable in degenerative MS. The values of mean gradient and
systolic pulmonary artery pressure depend on several factors and should be only supportive
signs and should not be considered as surrogate markers of the severity of MS. (Cardiol J 2011;
18, 5: 577–580)
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Introduction
Unlike other valve diseases, the predominant
cause of mitral stenosis (MS) remains rheumatic fe-
ver. The main mechanism is commissural fusion. Oth-
er anatomic lesions are chordal shortening and fusion
and leaflet thickening and calcification. The calcifica-
tion seen in rheumatic MS usually involves the com-
missures and the leaflet tissue, with only late exten-
sion to the annulus. Rarely, in only 1% of cases, MS
is due to other causes such as congenital, or caused
by left atrial tumors, thrombi or vegetations [1, 2].
An unusual but documented cause of severe
MS is also heavy calcification of the mitral valve
annulus. Rheumatic MS differs markedly from
degenerative calcific MS, in which the main le-
sion is annular calcification resulting in limiting
anatomic orifice area. This entity, common in
elderly women, is a frequent cause of non-sig-
nificant mitral regurgitation (MR) and is associa-
ted with coronary atherosclerosis and cere-
brovascular embolic events, while severe, symp-
tomatic valve stenosis due to this cause is
extremely rare [1–4].
We present the case of a woman with severe
symptomatic degenerative calcific MS and we dis-
cuss the echocardiographic criteria used in order to
quantify the severity of stenosis.
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Case report
A 72 year-old Caucasian woman was admitted
to our hospital with symptoms of gradually increas-
ing shortness of breath, primarily on exertion, dur-
ing the last six months. She also claimed some epi-
sodes of paroxysmal nocturnal dyspnea without the
pain associated with dyspnea.
The physical examination revealed a soft dias-
tolic murmur localized at the apex. Resting electro-
cardiogram showed sinus rhythm with a heart rate
of 80 bpm. Chest X-ray revealed mild cardiomega-
ly with left atrial enlargement.
Transthoracic echocardiography demonstrated
normal left ventricular size and function, enlarged
left atrium and normal right cavities. From the mild
tricuspid regurgitation, the pulmonary arterial sys-
tolic pressure was estimated at 55–60 mm Hg.
Heavy calcification was obvious in the mitral valve
orifice at both the anterior and posterior aspect of
the annulus. The tips were relatively free and the
leaflets opened without doming restriction (Fig. 1).
Planimetry measurement of the mitral orifice
using two-dimensional (2D) echocardiography was
not feasible because of the poor acoustic window
and the existence of severe annular calcification.
Continuous-wave Doppler of the transmitral flow is
depicted in Figure 2. The mean mitral valve gra-
dient was 13 mm Hg, consistent with severe MS.
Pressure half-time (PHT) derived mitral valve
area (MVA) was calculated using the following for-
mula: MVA = 220/PHT. PHT is obtained by trac-
ing the deceleration slope of the E-wave on Dop-
pler spectral display of transmitral flow. In our case,
PHT was 138 ms (Fig. 2). Thus, MVA = 220/138
= 1.6 cm2, suggesting mild mitral stenosis.
In this particular case of degenerative MS, we
also estimated the MVA using the continuity equa-
tion: MVA = p × (D2/4) × (VTI aortic/VTI mitral),
where D = 2 cm was the diameter of the left ven-
tricular outflow track (LVOT) and VTI (velocity time
interval) aortic = 15 cm and VTI mitral = 52 cm.
VTI aortic was measured from the LVOT velocities
recorded by pulsed Doppler and VTI mitral from the
MS jet velocities by continuous-wave Doppler.
Thus, MVA = 3.14 × (2²/4) × (15/52) = 0.91 cm2,
suggesting severe stenosis.
Discussion
Mitral annulus calcification is a degenerative
calcific process of the mitral valve support ring. It
is a common finding in the elderly, especially in
women, often with coexisting hypertension, coro-
nary artery disease and diabetes mellitus [2, 4]. It
essentially involves the posterior annulus, with
minimal extension to leaflets and chordae. This
entity can be isolated causing few or no hemody-
namic consequences, or associated with MR rather
than MS. Generally it is not associated with clini-
cally important flow obstruction [3, 5]. Akram et al.
[6] found that out of 70 patients reporting as hav-
ing MS, 18.5% had calcific mild to moderate MS
rather than rheumatic MS.
Nevertheless, severe degenerative MS is ex-
tremely rare and occurs when calcification extends
to the basis of mitral leaflets resulting in narrow-
ing of the diastolic flow area, without tips restric-
tion unlike rheumatic MS [5, 6]. Reduction of nor-
mal mitral annular dilatation during diastole and the
Figure 2. Transmitral Doppler derived mean gradient
(MEAN GR) and pressure-half time (PHT).
Figure 1. Two-dimensional echocardiogram. Apical
four-chamber view showing the heavily calcified mitral
annulus with free leaflet tips (arrow); LA — left atrium;
LV — left ventricle.
579
Maria Bonou et al., Degenerative mitral stenosis
www.cardiologyjournal.org
addition of impaired anterior mitral leaflet mobility
appeared to be possible mechanisms for the signifi-
cant functional stenosis caused by calcification of
mitral valve annulus [5, 7]. It is more frequently
encountered in patients with advanced renal disease
requiring dialysis [8].
An accurate measurement of MVA in degene-
rative calcific MS is problematic. In our case, there
was a discrepancy in the measurements of the MVA
using echocardiographic methods.
Transvalvular mean gradient is not the best
marker of the severity of MS since it is related to
the MVA but it is also influenced by a number of
other factors, the most important being heart rate,
cardiac output and associated MR [3]. The values
of mean gradient and systolic pulmonary artery
pressure should be only supportive signs and can-
not be considered as surrogate markers of the se-
verity of MS.
Accurate measurement of MVA is essential in
the evaluation of patients with MS. The gold stan-
dard method has been invasive evaluation using the
Gorlin equation to derive a calculated valve area [3].
However, cardiac catheterization is an invasive
method, it has several limitations and should be
restricted to the rare cases where echocardiography
is inconclusive or discordant with clinical findings.
In clinical practice, 2D and Doppler echocar-
diography has been the usual method to determine
indirectly the MVA by PHT or by direct planime-
try. The PHT derived MVA is limited and often in-
accurate in patients with calcific annular MS be-
cause there are frequently coexisting conditions,
such as hypertension and diabetes mellitus, that
impair left ventricular compliance and thus alter left
atrial to left ventricular pressure difference [9].
Therefore the PHT would be shorter as a result of
a more rapid equilibration of left atrial and ventri-
cular pressure, resulting in an overestimation of the
MVA, which was our experience in this case. On
the other hand, not all prolonged PHTs indicate MS.
Patients with abnormal myocardial relaxation have
a prolonged PHT without valve stenosis. Hence,
according to the EAE/ASE recommendations for
echocardiographic assessment of valve stenosis, the
use of PHT in degenerative calcific MS may be un-
reliable and should be avoided [3].
Planimetry using 2D is considered as the re-
ference measurement of MVA. It is a direct and re-
lative hemodynamic-independent method without
the need for geometric or mathematical assump-
tions [3]. However, planimetry and PHT methods
have a better correlation with anatomical valve area
in younger patients with rheumatic MS than in cal-
cific annular MS [6]. In the case of degenerative MS,
planimetry is difficult and mostly not reliable. This
may be related to both the presence of heavy calcifi-
cation and the fact that the limiting orifice is near the
annulus and does not present an area for planimetry
at the leaflet tips as in rheumatic MS [3, 10]. The
PHT derived MVA has limitations in patients with
calcific annular MS in whom there are coexisting
conditions, such as hypertension and diabetes mel-
litus, that impair left ventricular compliance and thus
alter left atrial to left ventricular pressure difference.
Therefore, the PHT would be shorter as a result of
a more rapid equilibration of left atrial and ventricu-
lar pressure, resulting in an overestimation of the
MVA, which was our experience in this case.
The continuity equation method is an indepen-
dent standard for measuring the effective MVA in
degenerative MS, correlating well with invasive
methods [3, 10]. On the other hand, it is technical-
ly demanding and requires multiple measurements,
increasing the impact of errors. This is why it is not
recommended for routine use in MS but may be
useful in certain patients, as in our case, when stan-
dard measurements are inconclusive [3].
Recent reports demonstrate that real-time 3D
echocardiography provides an accurate measure-
ment of MVA in both rheumatic and degenerative
MS [10, 11]. Chu et al. [10], used 3D color-plani-
metry to measure MVA in calcific MS and compared
this method to PHT derived MVA, considering con-
tinuity equation as an independent standard. Real-
time 3D echocardiography had a greater correlation
and agreement to MVA by continuity equation than
MVA by PHT. This reflects the tubular valve geo-
metry of mitral valve orifice in these patients [10].
2D planimetry has limitations, particularly in regard
to positioning the correct image plane orientation.
This is even more pronounced in degenerative cal-
cific MS because the limiting orifice is near the
annulus and not at the leaflet tips as in rheumatic
MS. In addition 2D planimetry is limited to those
patients in whom parasternal images of high quality
can be obtained [10, 11]. 3D echocardiography over-
comes these limitations, enables appropriate orien-
tation and provides the optimal plane of the smallest
mitral valve orifice. In addition, 3D planimetry is not
limited to the parasternal view and allows MVA
measurements from an apical view [10, 11].
Other echocardiographic findings in degene-
rative MS, as reported by Akram et al. [6], are high-
er mitral annulus calcification severity score, low-
er frequency of significant MR, milder degree of
MS, higher frequency of concomitant aortic steno-
sis and higher left ventricular mass compared to
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rheumatic MS. The last finding may reflect the high
prevalence of hypertension in this group of patients.
Replacement of the mitral valve in the pre-
sence of extensive annular calcification can be ex-
tremely difficult and challenging. Calcification in-
terferes with suture placement and prevents pro-
per insertion of a prosthesis, increasing the
possibility of paravalvular leakage and valvular de-
hiscence. Aggressive debridement of a calcified an-
nulus may lead to atrioventricular groove rupture,
injury of the circumflex coronary artery or throm-
boembolic events [12, 13]. Several surgical tech-
niques have been proposed to deal with MS due to
extensive calcification of mitral annulus. In patients
with heavy circumferential annular calcification,
these approaches can often be unfeasible. In these
cases, mitral prosthesis can be implanted at the in-
tra-atrial level [13].
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